Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
  1. 4 Option exercise EVP, Chief Development Officer acquired 23,464 shares (option exercise)
  2. 4 Option exercise EVP, Chief Financial Officer acquired 25,229 shares (option exercise)
  3. 4 Option exercise Chief Executive Officer acquired 84,810 shares (option exercise)
  4. 4 Option exercise EVP, Chief Development Officer acquired 3,874 shares (option exercise)
  5. 4 Option exercise Chief Executive Officer acquired 13,797 shares (option exercise)
  6. 4 Option exercise EVP, Chief Financial Officer acquired 3,874 shares (option exercise)
  7. 4 Option exercise Chief Executive Officer acquired 62,500 shares (option exercise)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 53,960 shares (grant or award)
  10. 4 Grant or award Director acquired 53,960 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award Director acquired 53,960 shares (grant or award)
  13. 4 Grant or award Director acquired 53,960 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Director acquired 53,960 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award Director acquired 53,960 shares (grant or award)
  18. 4 Option exercise EVP, Chief Financial Officer acquired 11,695 shares (option exercise)
  19. 4 Option exercise EVP, Chief Development Officer acquired 11,695 shares (option exercise)
  20. 4 Option exercise Chief Executive Officer acquired 34,789 shares (option exercise)

Page 2 of 30 · 585 filings